NCT06686641

Incidence of Macular Edema in a Uveitis Population

Incidence of Macular Edema in a Uveitis Population of 1500 Patients

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,550 (actual)
• Sponsor: Aalborg University Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Macular edema from uveitis is a serious condition that can lead to vision loss. Uveitis is an inflammation inside the eye, and macular edema is when fluid builds up in the central part of the retina, called the macula, which is crucial for clear vision. This fluid buildup can blur vision, sometimes severely. Managing this condition can be challenging and may require several treatments to reduce the fluid and protect sight. While we know macular edema is a common cause of vision loss in uveitis, there's limited data on how often it affects people in Europe

Conditions

• Macular Edema
• Non-infectious Uveitis

Interventions

Type	Name	Description
DRUG	Local and systemical treatment	Evaluating the management of the edema including topical/local treatment (dexamethasone and NSAID, periocular injections, and dexamethasone intravitreal implant) and systemic treatment (prednisolone, DMARD, and biological agents, for example TNF-alpha inhibitors and interleukin-6 inhibitors). Moreover, the duration of any treatment as well as numbers of injections or implants.

Timeline

• Start date: 2024-05-01
• Primary completion: 2024-10-31
• Completion: 2025-02-01
• First posted: 2024-11-13
• Last updated: 2024-11-13

Locations

1 site across 1 country: Denmark